MARKET WIRE NEWS

Ondine Biomedical (OTCMKTS : OBIMF ) Stock

Share:

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.


Description


Ondine Biomedical Inc. is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of anti-infective therapies covering a various bacterial, fungal and viral infections primarily using antimicrobial photodynamic therapy (aPDT) as a platform technology for its products, which are used as an alternative to the use of antibiotics. The Company¿s aPDT products uses laser-based activation of compounds to treat a range of medical infections. Its Photodisinfection platform, is a light-based antimicrobial technology that provides rapid destruction of a range of pathogens without causing antibiotic resistance. The Company offers Steriwave product, which is a photodisinfection-based medical device to eliminate harmful nasal pathogens that can lead to healthcare-associated infections (HAIs).


Quote


Last:$0.17
Change Percent: -98.97%
Open:$0.17
Close:$0.17
High:$0.17
Low:$0.17
Volume:40,000
Last Trade Date Time:11/05/2025 09:30:48 am

Stock Data


Market Cap:$63,830,438
Float:256,829,848
Insiders Ownership:57.7%
Institutions:
Short Percent:N/A
Industry:Biotechnology & Life Sciences
Sector:Healthcare
Website:
Country:GB
City:Vancouver

Recent News Releases


Subscribe to Our Newsletter


Message Board Posts


**MWN-AI FAQ is based on asking OpenAI questions about Ondine Biomedical (OTCMKTS: OBIMF).

Link Market Wire News to Your X Account

Download The Market Wire News App